Sensitive ASX Announcement

Immuron Granted FDA pre-IND Meeting re Phase 2b Trial

Published: 19/04/11, 09:21am (AEST)1 pages
Immuron Limited
IMC:ASXHealthcare

Recent IMC Announcements

Price Sensitive only